Novabay Pharmaceuticals Inc (NBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBY | LITS | ATNM | ||
| Company | Novabay Pharmaceuticals Inc | Lite Strategy Inc | Actinium Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NYSE Arca | ||
| Open | 1.6800 | 1.1100 | 1.0600 | ||
| High | 1.7000 | 1.2150 | 1.1700 | ||
| Low | 1.5000 | 1.1000 | 1.0600 | ||
| Latest | 1.5500 | 1.1800 | 1.1400 | ||
| Change | -0.1000 | +0.0700 | +0.0700 | ||
| % Change | -6.06% | +6.31% | +6.54% | ||
| Volume | 507,300 | 712,100 | 174,200 | ||
| 20-Day Average Volume | 492,831 | 401,230 | 121,585 | ||
| Previous Close | 1.6500 | 1.1100 | 1.0700 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.3479 | 1.1101 | 1.1340 | ||
| 20-Day Raw Stochastic | 0.46% | 58.87% | 43.92% | ||
| 20-Day Relative Strength | 38.72 | 45.87 | 44.00 | ||
| Weighted Alpha | -63.57 | -71.99 | -10.61 | ||
| Today's Opinion | 40% Sell | 88% Sell | 88% Sell | ||
| Previous Opinion | 40% Sell | 100% Sell | 100% Sell | ||
| Last Month's Opinion | 40% Buy | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -28.60% since 02/18/26 | +7.27% since 02/18/26 | +9.62% since 02/18/26 | ||
| Low | 1.5000 on 02/25/26 | 1.0125 on 02/24/26 | 1.0300 on 02/24/26 | ||
| High | 3.7500 on 02/20/26 | 1.2150 on 02/25/26 | 1.1700 on 02/25/26 | ||
| 1-Month | |||||
| %Chg | -93.42% since 01/23/26 | -7.09% since 01/23/26 | -12.31% since 01/23/26 | ||
| Low | 1.5000 on 02/25/26 | 0.9510 on 02/05/26 | 1.0200 on 02/18/26 | ||
| High | 23.3000 on 01/26/26 | 1.3400 on 01/28/26 | 1.3000 on 01/26/26 | ||
| 3-Month | |||||
| %Chg | -67.02% since 11/25/25 | -35.87% since 11/25/25 | -18.57% since 11/25/25 | ||
| Low | 1.5000 on 02/25/26 | 0.9510 on 02/05/26 | 1.0200 on 02/18/26 | ||
| High | 99.7500 on 01/09/26 | 1.9900 on 11/26/25 | 1.7200 on 12/22/25 | ||
| 6-Month | |||||
| %Chg | -65.80% since 08/25/25 | -76.40% since 08/25/25 | -36.31% since 08/25/25 | ||
| Low | 1.5000 on 02/25/26 | 0.9510 on 02/05/26 | 1.0200 on 02/18/26 | ||
| High | 99.7500 on 01/09/26 | 5.5000 on 08/27/25 | 1.8059 on 08/26/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 40,179 | 42,907 | 35,563 | ||
| Shares Outstanding, K | 25,922 | 36,362 | 31,196 | ||
| Annual Sales | 9,780,000 | 0 | 0 | ||
| Annual Net Income | -7,220,000 | -15,950,000 | -38,240,000 | ||
| Last Quarter Sales | 520,000 | 0 | 90,000 | ||
| Last Quarter Net Income | -1,290,000 | -30,800,000 | -5,130,000 | ||
| 60-Month Beta | 0.14 | 0.32 | -0.30 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.23 on 11/07/25 | -0.12 on 11/14/25 | -0.16 on 11/14/25 | ||
| Latest Earnings Date | 04/01/26 | 05/12/26 | 03/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||